戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 erwent magnetic resonance imaging to exclude arrhythmogenic right ventricular dysplasia.
2 orphic ventricular tachycardia and a form of arrhythmogenic right ventricular dysplasia.
3 rces for arrhythmias, even in the absence of arrhythmogenic right ventricular dysplasia.
4  detailed echocardiography, in patients with arrhythmogenic right ventricular dysplasia.
5 r therapy in the management of patients with arrhythmogenic right-ventricular dysplasia.
6 gnetic resonance imaging in the diagnosis of arrhythmogenic right-ventricular dysplasia.
7 netically uncharacterized diseases including arrhythmogenic right ventricular dysplasia 3.
8 yopathy, left ventricular noncompaction, and arrhythmogenic right ventricular dysplasia; and delineat
9 lymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventricular dysplasia (ARVD) affect
10 etic resonance imaging (MRI) examinations of arrhythmogenic right ventricular dysplasia (ARVD) and to
11    The loci of several genes responsible for arrhythmogenic right ventricular dysplasia (ARVD) have b
12                                              Arrhythmogenic right ventricular dysplasia (ARVD) is an
13          Ventricular tachycardia ablation in arrhythmogenic right ventricular dysplasia (ARVD) is mor
14                                              Arrhythmogenic right ventricular dysplasia (ARVD), a fam
15  study was to reevaluate the ECG features of arrhythmogenic right ventricular dysplasia (ARVD).
16 es in probands who were newly diagnosed with arrhythmogenic right ventricular dysplasia (ARVD).
17 r tachycardia (VT) ablation in patients with arrhythmogenic right ventricular dysplasia (ARVD).
18 ve recently localized a gene responsible for arrhythmogenic right ventricular dysplasia (ARVD).
19 where we have mapped a locus responsible for arrhythmogenic right ventricular dysplasia (ARVD).
20 e applied to ventricular tachycardia (VT) in arrhythmogenic right ventricular dysplasia (ARVD).
21                                              Arrhythmogenic right-ventricular dysplasia (ARVD), a car
22 r structural abnormalities characteristic of arrhythmogenic right ventricular dysplasia, but right ve
23 earch has described the arrhythmic course of arrhythmogenic right ventricular dysplasia/cardiomyopath
24 entricular contractions (PVCs) are common in arrhythmogenic right ventricular dysplasia/cardiomyopath
25                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
26                   We hypothesized that VT in arrhythmogenic right ventricular dysplasia/cardiomyopath
27 entricular arrhythmias in patients harboring arrhythmogenic right ventricular dysplasia/cardiomyopath
28 ermine how exercise influences penetrance of arrhythmogenic right ventricular dysplasia/cardiomyopath
29 hythmic risk stratification in patients with arrhythmogenic right ventricular dysplasia/cardiomyopath
30 The study population included 16 consecutive arrhythmogenic right ventricular dysplasia/cardiomyopath
31 acycline cardiomyopathy, cardiac tumors, and arrhythmogenic right ventricular dysplasia/cardiomyopath
32 r tachycardia (VT) ablation in patients with arrhythmogenic right ventricular dysplasia/cardiomyopath
33                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
34                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
35 ricular tachycardia (VT) among patients with arrhythmogenic right ventricular dysplasia/cardiomyopath
36 icular arrhythmias distinguish patients with arrhythmogenic right ventricular dysplasia/cardiomyopath
37 defibrillator (ICD) therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopath
38 lying right ventricular (RV) dyssynchrony in arrhythmogenic right ventricular dysplasia/cardiomyopath
39 ent in individuals predisposed to developing arrhythmogenic right ventricular dysplasia/cardiomyopath
40 ion (RFA) of ventricular tachycardia (VT) in arrhythmogenic right ventricular dysplasia/cardiomyopath
41 s have been identified as the major cause of arrhythmogenic right ventricular dysplasia/cardiomyopath
42                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
43                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
44                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
45                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
46                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
47 M and they were diagnostic or suggestive for arrhythmogenic right ventricular dysplasia/cardiomyopath
48 utations among family members of people with arrhythmogenic right ventricular dysplasia/cardiomyopath
49                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
50 RI) for noninvasive detection of fibrosis in Arrhythmogenic right ventricular dysplasia/cardiomyopath
51 ow overlap in the clinical presentation with arrhythmogenic right ventricular dysplasia/cardiomyopath
52                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
53 m of this study was to assess the outcome of arrhythmogenic right ventricular dysplasia/cardiomyopath
54                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
55 ovirus (CMV), enterovirus and parvovirus, in arrhythmogenic right ventricular dysplasia/cardiomyopath
56 diomyopathy (ie, restrictive cardiomyopathy, arrhythmogenic right ventricular dysplasia/cardiomyopath
57 lete penetrance and variable expressivity of arrhythmogenic right ventricular dysplasia/cardiomyopath
58 can in turn facilitate ablation of the VT in arrhythmogenic right ventricular dysplasia/cardiomyopath
59 imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopath
60                                              Arrhythmogenic right ventricular dysplasia/cardiomyopath
61                The majority of patients with arrhythmogenic right ventricular dysplasia have abnormal
62           Mutations in PTPLa correlated with arrhythmogenic right ventricular dysplasia in humans and
63 d the pathogenesis of both Uhl's anomaly and arrhythmogenic right ventricular dysplasia; in each apop
64                                              Arrhythmogenic right-ventricular dysplasia is a rare dis
65                                              Arrhythmogenic right-ventricular dysplasia is a rare inh
66 nt new breakthroughs in the genetic basis of arrhythmogenic right-ventricular dysplasia; it now appea
67                Selected reports suggest that arrhythmogenic right ventricular dysplasia may be a more
68 pertrophic cardiomyopathy, and patients with arrhythmogenic right ventricular dysplasia or channelopa
69                         This may explain why arrhythmogenic right-ventricular dysplasia preferentiall
70  Ten patients with the clinical diagnosis of arrhythmogenic right ventricular dysplasia were included

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。